Neurogene (NGNE) Current Leases (2018 - 2026)

Neurogene (NGNE) has 9 years of Current Leases data on file, last reported at $9000.0 in Q1 2026.

• Quarterly Current Leases fell 81.25% year-over-year to $9000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $9000.0 (down 81.25% YoY) and the FY2025 annual result came in at $14000.0, down 74.07% from the prior year.
• Current Leases slipped to $9000.0 in Q1 2026, from $14000.0 in the prior quarter.
• In the past five years, Current Leases ranged from a high of $3.1 million in Q2 2025 to a low of $4000.0 in Q3 2023.
• A 5-year average of $1.2 million and a median of $678000.0 in 2022 frame the typical range for Current Leases.
• Annual changes were most pronounced in 2023 — Current Leases tumbled 99.7% — and 2024, when it soared 71300.0%.
• Tracing NGNE's Current Leases over 5 years: stood at $678000.0 in 2022, then sank by 93.81% to $42000.0 in 2023, then gained by 28.57% to $54000.0 in 2024, then tumbled by 74.07% to $14000.0 in 2025, then tumbled by 35.71% to $9000.0 in 2026.
• The last three Current Leases figures came in at $9000.0 (Q1 2026), $14000.0 (Q4 2025), and $3.1 million (Q3 2025), per Business Quant data.